Byron Bassett serves as an executive at Key Pharmaceuticals, overseeing strategic initiatives and leadership responsibilities.
| Company | Designation | Period |
|---|---|---|
| Dyson | Finance and Operations Director | Sep 2017 – Feb 2020 |
| Activision | Financial Controller | Nov 2014 – May 2016 |
| Woolworths Limited | Commercial Manager - Marketing | Nov 2013 – Oct 2014 |
| Dyson | Head of Strategy, Analytics and Commercial Finance | May 2016 – Sep 2017 |
| Johnson & Johnson Consumer Health | Business Unit Director - Essential Health | Mar 2022 – Mar 2024 |
| GlaxoSmithKline | Commercial Manager | Mar 2012 – Jan 2013 |
| Johnson & Johnson Consumer Health | Chief Financial Officer - ANZ | Feb 2020 – Sep 2022 |
| Key Pharmaceuticals | Chief Financial Officer | Jul 2024 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Key Pharmaceuticals corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Byron Bassett's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Key Pharmaceuticals's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)